10 completed, 6 unknown, 2 recruiting, 1 active not recruiting. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Completed 10, Unknown 6, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1 |
Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo. Non-cultured epidermal cell suspension (NCES) surgery, Oral mini pulse, Excimer Sessions - Vitiligo | Phase 4 | Not yet recruiting | Cairo University | 60 | 2026-03-15 | 2026-03-16 |
| The Value of Methotrexate in NCES for Stable Vitiligo Non cultured epidermal suspension - Vitiligo | Phase 4 | Completed | Cairo University | 21 | 2026-03-03 | 2026-09-30 |
| Oral Mini Pulse Dexamethasone in Pediatric Vitiligo Dexamethasone (0.1 mg/kg) - Vitiligo | Phase 4 | Completed | Cairo University | 22 | 2026-02-28 | 2026-09-01 |
| Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial ruxolitinib cream - Vitiligo | Phase 4 | Completed | Dow University of Health Sciences | 120 | 2025-04-06 | 2026-01-26 |
| Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients Needling + NBUVB, Microneedling + NBUVB - Vitiligo, Non-segmental Vitiligo | Phase 4 | Recruiting | Khyber Teaching Hospital | 80 | 2025-03-01 | 2025-09-02 |
| A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients. Narrow Band UVB Treatment, blue light emitting diode - Vitiligo | Phase 4 | Completed | Cairo University | 30 | 2025-01-20 | 2025-09-15 |
| Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients Apremilast with NB-UVB, NB-UVB - Vitiligo | Phase 4 | Enrolling by invitation | Dow University of Health Sciences | 30 | 2025-01-01 | 2025-03-11 |
| Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy. NB-UVB alone, NB-UVB combined with carboxy - Vitiligo Vulgaris | Phase 4 | Active not recruiting | Kasr El Aini Hospital | 59 | 2024-09-15 | 2026-05-01 |
| Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo a new effervescent mixture 5-florouracil formula, 5-Fluorouracil plain powder - Vitiligo, Topical Fluorouracil | Phase 4 | Recruiting | Al-Azhar University | 60 | 2022-10-15 | 2026-01-06 |
| Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo Methotrexate, 5-fluorouracil, Fractional CO2 laser - Vitiligo | Phase 4 | Unknown | Assiut University | 50 | 2022-09-01 | 2022-05-09 |
| Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo diphenylcyclopropenone (DPCP) - Vitiligo | Phase 4 | Completed | Ain Shams University | 20 | 2021-01-17 | 2023-04-11 |
| Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo Topical travoprost 0.004% solution, Fractional CO2 laser, Excimer laser - Vitiligo, Excimer Laser | Phase 4 | Unknown | Assiut University | 30 | 2021-01-01 | 2020-10-22 |
| Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo NB-UVB, NB-UVB & Tacrolimus 0.03% - Vitiligo | Phase 4 | Unknown | South Valley University | 100 | 2017-09-01 | 2018-09-06 |
| Secukinumab in Active Non-segmental Vitiligo Secukinumab - Vitiligo, Secukinumab | Phase 4 | Completed | University Hospital, Ghent | 8 | 2016-10-12 | 2023-02-10 |
| Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients ReCell, Full surface CO2 laser 200 mJ, Full surface CO2 laser 150 mJ - Segmental Vitiligo, Piebaldism | Phase 4 | Completed | Netherlands Institute for Pigment Disorders | 10 | 2015-05-01 | 2017-04-04 |
| NB-UVB and PUVA Vitiligo Study Phototherapy, Phototherapy and Photochemotherapy - Vitiligo | Phase 4 | Completed | Henry Ford Health System | 10 | 2013-03-01 | 2017-02-23 |
| Punchgrafting Techniques for Vitiligo punchgrafting - Non-segmental Vitiligo, Segmental Vitiligo | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 35 | 2011-06-01 | 2011-06-21 |
| Topical Bimatoprost Solution 0.03%in Stable Vitiligo Bimatoprost 0.03% topical ophthalmic solution - Vitiligo, Repigmentation | Phase 4 | Withdrawn | Gian Sagar Medical College and Hospital | 20 | 2010-08-01 | 2011-08-03 |
| Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) topical tacrolimus treatment, topical pimecrolimus treatment, local mometasone furoate treatment - Vitiligo | Phase 4 | Completed | University Hospital, Ghent | 14 | 2010-02-16 | 2022-12-08 |
| Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo Fluticasone proprionate 0.05% cream - Patients With Active Non-segmental Vitiligo., Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05% | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 50 | 2009-09-01 | 2010-11-24 |
Showing 20 of 22. Sign in to see all of them.
Piebaldism (2) · Personal Satisfaction (1)
Hypopigmentation (22) · Pigmentation Disorders (22) · Skin Diseases (22) · Skin and Connective Tissue Diseases (22) · Albinism (2) · Amino Acid Metabolism, Inborn Errors (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2) · Skin Diseases, Genetic (2) · Behavior (1)
Bimatoprost (1) · Botulinum Toxins, Type A (1) · Combined Modality Therapy (1) · Dexamethasone (1) · Fluorouracil (1) · Lasers, Excimer (1) · Methotrexate (1) · Mometasone Furoate (1) · Ophthalmic Solutions (1) · Percutaneous Collagen Induction (1) · Photochemotherapy (1) · Phototherapy (1) · Solutions (1) · Surgical Procedures, Operative (1) · Tacrolimus (1)
Cairo University (4) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Assiut University (2) · Dow University of Health Sciences (2) · University Hospital, Ghent (2) · Ain Shams University (1) · Al-Azhar University (1) · Gian Sagar Medical College and Hospital (1) · Henry Ford Health System (1) · Kasr El Aini Hospital (1) · Khyber Teaching Hospital (1) · King Saud University (1) · Mahidol University (1) · Netherlands Institute for Pigment Disorders (1) · South Valley University (1)
Egypt (8) · Netherlands (3) · Pakistan (3) · Belgium (2) · Saudi Arabia (1) · Thailand (1) · United States (1)
Albert Wolkerstorfer, MD, PhD (1) · Chanisada Wongpraparut, M.D. (1) · Ghada Binsaif, MD (1) · Huma Gul Doctor, MBBS (1) · Iltefat Hamzavi, MD (1) · Marwa MA Abdallah (1) · Menno A. De Rie, MD, PhD (1) · Nanny Van Geel, MD, PhD (1) · Rajeev Jain, M.D. (1) · Ramdan Saleh, MD (1) · Rania M Elhusseiny (1) · Tarun Narang, MD (1) · van Geel Nanja, MD, PhD (1)